Page last updated: 2024-12-05

acetyleugenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Acetyleugenol is a synthetic compound derived from eugenol, a natural phenolic compound found in essential oils of plants like cloves. It is synthesized through acetylation of eugenol, typically using acetic anhydride and a catalyst. Acetyleugenol exhibits various pharmacological activities, including antimicrobial, antifungal, antioxidant, and analgesic properties. It has been investigated for its potential therapeutic applications in treating infections, inflammation, and pain. Research interest in acetyleugenol stems from its natural origin, diverse biological activities, and potential as a lead compound for drug development. Studies focus on understanding its mechanisms of action, optimizing its synthesis, and exploring its efficacy in various therapeutic contexts.'

acetyleugenol: from cloves; inhibits arachidonate-, adrenaline-, & collagen-induced platelet aggregation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7136
CHEMBL ID108299
CHEMBL ID108299 V9OSB376X8
CHEBI ID34522
CHEBI ID34522 SCCDQYPEOIRVGX-UHFFFAOYSA-N (2-METHOXY-4-PROP-2-ENYLPHENYL)
SCHEMBL ID112232
MeSH IDM0218472

Synonyms (79)

Synonym
BIDD:ER0670
aceto eugenol
AKOS015837940
phenol, 2-methoxy-4-(2-propenyl)-, acetate
phenol, 4-allyl-2-methoxy-, acetate
2-methoxy-4-(2-propenyl)phenyl acetate
1,3,4-eugenol acetate
brn 1964745
fema no. 2469
ai3-01780
einecs 202-235-6
nsc 1242
2-methoxy-4-(2-propen-1-yl)phenyl acetate
inchi=1/c12h14o3/c1-4-5-10-6-7-11(15-9(2)13)12(8-10)14-3/h4,6-8h,1,5h2,2-3h
eugenyl acetate ,
93-28-7
1,4-eugenol acetate
1-acetoxy-2-methoxy-4-allylbenzene
aceteugenol
nsc-1242
acetyleugenol
4-allyl-2-methoxyphenyl acetate
4-allyl-2-methoxyphenol acetate
wln: 1vor bo1 d2u1
eugenol acetate
nsc1242
eugenyl acetate, >=98%, fcc, fg
acetyl eugenol
acetic acid 4-allyl-2-methoxy-phenyl ester
bdbm50240728
(2-methoxy-4-prop-2-enylphenyl) acetate
chebi:34522 ,
CHEMBL108299 ,
BMSE010055
1-(3-methoxy-4-acetoxyphenyl)-2-propene
E0210
A844505
acetat
v9osb376x8 ,
3-06-00-05029 (beilstein handbook reference)
unii-v9osb376x8
phenol, 2-methoxy-4-(2-propen-1-yl)-, 1-acetate
S9377
FT-0626370
eugenolacetate
eugenol acetate [fhfi]
eugenyl acetate [inci]
eugenyl acetate [fcc]
3-(4-acetoxy-3-methoxyphenyl)propene
SCHEMBL112232
DTXSID5052624 ,
2-methoxy-4-(prop-2-en-1-yl)phenyl acetate
mfcd00026191
acetyleugenol, analytical standard
eugenyl acetate, >=98%, fcc
2-methoxy-4-(prop-2-enyl)phenyl acetate (acetyleugenol)
fema 2469
Q27116129
CCG-266622
CS-W015328
HY-W014612
eugenol acetate 1000 microg/ml in acetonitrile
AS-56614
Z28076598
dtxcid9031197
1-acetate ai3-01780
11eua7501
2-methoxy-4-(2-propen-1-yl)-
acet eugenol
acetate nsc 1242 unii-v9osb376x8
chebi:34522 sccdqypeoirvgx-uhfffaoysa-n (2-methoxy-4-prop-2-enylphenyl)
1-acetoxy-2-methoxy-4-allylbenzene phenol
4-allyl-2-methoxy-
acetyl eugenol fg 25
acetate 2-methoxy-4-(prop-2-en-1-yl)phenyl acetate
2-methoxy-4-(2-propenyl)-
brn 1964745 phenol
chembl108299 v9osb376x8
acetate phenol

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Bioactives compounds are often toxic at high doses."( Toxicity of clove essential oil and its ester eugenyl acetate against Artemia salina.
Cansian, RL; Cardoso, RI; Gonçalves, IL; Honaiser, TC; Oliveira, D; Orlando, T; Paroul, N; Piazza, SP; Puton, BM; Vanin, AB, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
benzoate esterEsters of benzoic acid or substituted benzoic acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
Olfactory Signaling Pathway8028
Sensory Perception21568

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Prostaglandin G/H synthase 1Homo sapiens (human)IC50 (µMol)3.00000.00021.557410.0000AID403341
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (6)

Processvia Protein(s)Taxonomy
prostaglandin biosynthetic processProstaglandin G/H synthase 1Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 1Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 1Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 1Homo sapiens (human)
regulation of cell population proliferationProstaglandin G/H synthase 1Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (6)

Processvia Protein(s)Taxonomy
peroxidase activityProstaglandin G/H synthase 1Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 1Homo sapiens (human)
protein bindingProstaglandin G/H synthase 1Homo sapiens (human)
heme bindingProstaglandin G/H synthase 1Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 1Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (7)

Processvia Protein(s)Taxonomy
photoreceptor outer segmentProstaglandin G/H synthase 1Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 1Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 1Homo sapiens (human)
Golgi apparatusProstaglandin G/H synthase 1Homo sapiens (human)
intracellular membrane-bounded organelleProstaglandin G/H synthase 1Homo sapiens (human)
extracellular exosomeProstaglandin G/H synthase 1Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 1Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (29)

Assay IDTitleYearJournalArticle
AID1501095Antileishmanial activity against Leishmania donovani MHOM/IN/AG/83 promastigotes after 48 hrs by MTT assay2017European journal of medicinal chemistry, Oct-20, Volume: 139Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
AID1501097Cytotoxicity against mouse RAW264.7 cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Oct-20, Volume: 139Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
AID1501101Induction of NO generation in Leishmania donovani MHOM/IN/AG/83 infected BALB/c mouse peritoneal macrophages assessed as nitrite levels after 48 hrs by Griess assay relative to untreated control2017European journal of medicinal chemistry, Oct-20, Volume: 139Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
AID403341Inhibition of COX12005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID1501098Cytotoxicity against BALB/c mouse peritoneal macrophages after 48 hrs by MTT assay2017European journal of medicinal chemistry, Oct-20, Volume: 139Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
AID1102054Acaricidal activity against Dermatophagoides farinae assessed as mortality at 25.5 ug/cm2 applied as fumes in closed container after 24 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1102088Ratio of benzyl benzoate LD50 to compound LD50 for Dermatophagoides farinae2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1167370Cytotoxicity against mouse RAW264.7 cells assessed as cell survival at 100 ug/ml after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Thymol and eugenol derivatives as potential antileishmanial agents.
AID1102053Acaricidal activity against Dermatophagoides farinae assessed as mortality at 25.5 ug/cm2 applied as fumes in open container after 24 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1501096Antileishmanial activity against Leishmania donovani MHOM/IN/AG/83 amastigotes infected in BALB/c mouse peritoneal macrophages after 42 hrs by Giemsa staining-based microscopic analysis2017European journal of medicinal chemistry, Oct-20, Volume: 139Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
AID1102051Acaricidal activity against Dermatophagoides pteronyssinus assessed as mortality at 25.5 ug/cm2 applied as fumes in open container after 24 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1167369Antileishmanial activity against intracellular Leishmania infantum chagasi MHOM/BR/00/1669 amastigotes infected in mouse RAW264.7 cells assessed as inhibition of parasite growth after 48 hrs2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Thymol and eugenol derivatives as potential antileishmanial agents.
AID1102066Acaricidal activity against Dermatophagoides farinae assessed as mortality at 19.1 ug/cm2 after 72 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1102058Acaricidal activity against Dermatophagoides pteronyssinus assessed as mortality at 15.9 to 19.1 ug/cm2 after 24 to 72 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1102087Acaricidal activity against Dermatophagoides pteronyssinus after 24 hr by fabric disk assay2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID166551Percentage inhibition against release of beta-hexosaminidase from RBL-2H3 cells at 100 uM from control2003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
Antiallergic principles from Alpinia galanga: structural requirements of phenylpropanoids for inhibition of degranulation and release of TNF-alpha and IL-4 in RBL-2H3 cells.
AID1102065Acaricidal activity against Dermatophagoides farinae assessed as mortality at 15.9 ug/cm2 after 72 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1102083Acaricidal activity against Dermatophagoides farinae assessed as mortality at 19.1 ug/cm2 after 24 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1167371Antileishmanial activity against intracellular Leishmania infantum chagasi MHOM/BR/00/1669 amastigotes infected in BALB/c mouse assessed as inhibition of parasite growth in spleen at 100 mg/kg, ip once daily treated after 30 days post infection for 30 day2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Thymol and eugenol derivatives as potential antileishmanial agents.
AID1501099Therapeutic index, ratio of IC50 for mouse RAW264.7 cells to IC50 for Leishmania donovani MHOM/IN/AG/83 promastigotes2017European journal of medicinal chemistry, Oct-20, Volume: 139Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
AID1102072Acaricidal activity against Dermatophagoides farinae assessed as mortality at 15.9 ug/cm2 after 48 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1102052Acaricidal activity against Dermatophagoides pteronyssinus assessed as mortality at 25.5 ug/cm2 applied as fumes in closed container after 24 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1102082Acaricidal activity against Dermatophagoides farinae assessed as mortality at 15.9 ug/cm2 after 24 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1102086Ratio of benzyl benzoate LD50 to compound LD50 for Dermatophagoides pteronyssinus2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1167372Antileishmanial activity against intracellular Leishmania infantum chagasi MHOM/BR/00/1669 amastigotes infected in BALB/c mouse assessed as inhibition of parasite growth in liver at 100 mg/kg, ip once daily treated after 30 days post infection for 30 days2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Thymol and eugenol derivatives as potential antileishmanial agents.
AID1501100Therapeutic index, ratio of EC50 for BALB/c mouse peritoneal macrophages to EC50 for Leishmania donovani MHOM/IN/AG/83 amastigotes2017European journal of medicinal chemistry, Oct-20, Volume: 139Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
AID1102089Acaricidal activity against Dermatophagoides farinae after 24 hr by fabric disk assay2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1167368Antileishmanial activity against axenically cultured Leishmania infantum chagasi MHOM/BR/00/1669 promastigotes infected in mouse RAW264.7 cells assessed as inhibition of parasite growth after 48 hrs2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Thymol and eugenol derivatives as potential antileishmanial agents.
AID1102073Acaricidal activity against Dermatophagoides farinae assessed as mortality at 19.1 ug/cm2 after 48 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (6.67)18.2507
2000's3 (20.00)29.6817
2010's6 (40.00)24.3611
2020's5 (33.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.80 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index5.14 (4.65)
Search Engine Demand Index44.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]